Test Code CRDPS Creatine Disorders Panel, Serum
Ordering Guidance
For additional diagnostic testing, consider ordering CRDPU / Creatine Disorders Panel, Random, Urine.
Additional Testing Requirements
To diagnose all creatine deficiency syndromes, order CRDPU / Creatine Disorders Panel, Random, Urine in addition to this test.
Necessary Information
Patient's age and sex are required.
Specimen Required
Supplies: Sarstedt Aliquot Tube 5 mL (T914)
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions: Centrifuge and aliquot serum into plastic vial. Send serum frozen.
Useful For
Evaluating patients with a clinical suspicion of arginine:glycine amidinotransferase deficiency,guanidinoacetate methyltransferase deficiency, and creatine transporter deficiency using serum specimens
Testing Algorithm
For more information see:
-Newborn Screen Follow-up for Guanidinoacetate Methyltransferase Deficiency
-Epilepsy: Unexplained Refractory and/or Familial Testing Algorithm
If the patient has abnormal newborn screening results for guanidinoacetate methyltransferase deficiency, refer to the appropriate ACMG Newborn Screening ACT Sheet.(1)
Special Instructions
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Creatine Disorders Panel, SSpecimen Type
SerumSpecimen Minimum Volume
0.1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | 
|---|---|---|
| Serum | Frozen (preferred) | 14 days | 
| Refrigerated | 7 days | |
| Ambient | 72 hours | 
Reject Due To
| Gross hemolysis | OK | 
| Gross lipemia | OK | 
| Gross icterus | OK | 
Reference Values
| 
 Creatine Disorders Panel Reference Values  | 
||||||
| 
 
  | 
 ≤11 Months  | 
 12-23 Months  | 
 24-35 Months  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 38.6-96.8  | 
 39.0-97.0  | 
 38.2-96.5  | 
 38.6-96.5  | 
 37.7-96.0  | 
 38.2-96.0  | 
| 
 Creatinine  | 
 27.6-35.9  | 
 27.6-35.2  | 
 27.6-36.5  | 
 27.6-35.5  | 
 27.6-37.1  | 
 27.6-36.0  | 
| 
 Guanidinoacetate  | 
 0.7-2.0  | 
 0.7-2.1  | 
 0.7-2.0  | 
 0.7-2.1  | 
 0.7-2.0  | 
 0.7-2.1  | 
| 
 Creatine/  | 
 ≤3.07  | 
 ≤3.60  | 
 ≤3.02  | 
 ≤3.54  | 
 ≤2.96  | 
 ≤3.48  | 
| 
 Guanidinoacetate/  | 
 ≤0.040  | 
 ≤0.040  | 
 ≤0.042  | 
 ≤0.040  | 
 ≤0.043  | 
 ≤0.042  | 
| 
 Guanidinoacetate/  | 
 ≤0.051  | 
 ≤0.081  | 
 ≤0.051  | 
 ≤0.080  | 
 ≤0.051  | 
 ≤0.079  | 
| 
 
  | 
 3 Years  | 
 4 Years  | 
 5 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 37.1-95.5  | 
 37.7-95.3  | 
 36.0-94.4  | 
 36.8-94.1  | 
 34.6-93.2  | 
 35.6-92.7  | 
| 
 Creatinine  | 
 27.6-37.9  | 
 27.7-36.9  | 
 27.6-39.3  | 
 27.7-38.2  | 
 27.6-40.9  | 
 27.8-39.9  | 
| 
 Guanidinoacetate  | 
 0.7-2.1  | 
 0.7-2.2  | 
 0.7-2.1  | 
 0.7-2.2  | 
 0.7-2.1  | 
 0.7-2.2  | 
| 
 Creatine/  | 
 ≤2.89  | 
 ≤3.40  | 
 ≤2.77  | 
 ≤3.26  | 
 ≤2.64  | 
 ≤3.09  | 
| 
 Guanidinoacetate/  | 
 ≤0.045  | 
 ≤0.043  | 
 ≤0.049  | 
 ≤0.045  | 
 ≤0.053  | 
 ≤0.049  | 
| 
 Guanidinoacetate/  | 
 ≤0.050  | 
 ≤0.077  | 
 ≤0.050  | 
 ≤0.075  | 
 ≤0.049  | 
 ≤0.072  | 
| 
 
  | 
 6 Years  | 
 7 Years  | 
 8 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 33.0-91.7  | 
 34.3-91.0  | 
 31.2-90.0  | 
 32.7-89.2  | 
 29.2-88.1  | 
 31.0-87.3  | 
| 
 Creatinine  | 
 27.6-42.8  | 
 28.0-41.9  | 
 27.7-44.9  | 
 28.3-44.3  | 
 27.8-47.0  | 
 28.8-47.1  | 
| 
 Guanidinoacetate  | 
 0.7-2.1  | 
 0.7-2.3  | 
 0.7-2.1  | 
 0.8-2.3  | 
 0.8-2.1  | 
 0.8-2.4  | 
| 
 Creatine/  | 
 ≤2.49  | 
 ≤2.91  | 
 ≤2.33  | 
 ≤2.70  | 
 ≤2.17  | 
 ≤2.49  | 
| 
 Guanidinoacetate/  | 
 ≤0.058  | 
 ≤0.053  | 
 ≤0.063  | 
 ≤0.058  | 
 ≤0.069  | 
 ≤0.064  | 
| 
 Guanidinoacetate/  | 
 ≤0.049  | 
 ≤0.069  | 
 ≤0.048  | 
 ≤0.066  | 
 ≤0.047  | 
 ≤0.063  | 
| 
 
  | 
 9 Years  | 
 10 Years  | 
 11 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 27.2-85.9  | 
 29.3-85.2  | 
 25.2-83.7  | 
 27.4-83.1  | 
 23.4-81.3  | 
 25.7-80.9  | 
| 
 Creatinine  | 
 28.0-49.3  | 
 29.5-50.1  | 
 28.2-51.5  | 
 30.6-53.6  | 
 28.4-53.6  | 
 32.0-57.2  | 
| 
 Guanidinoacetate  | 
 0.8-2.2  | 
 0.8-2.5  | 
 0.9-2.2  | 
 0.9-2.6  | 
 0.9-2.2  | 
 1.0-2.6  | 
| 
 Creatine/  | 
 ≤2.02  | 
 ≤2.28  | 
 ≤1.86  | 
 ≤2.07  | 
 ≤1.72  | 
 ≤1.87  | 
| 
 Guanidinoacetate/  | 
 ≤0.075  | 
 ≤0.070  | 
 ≤0.081  | 
 ≤0.078  | 
 ≤0.087  | 
 ≤0.085  | 
| 
 Guanidinoacetate/  | 
 ≤0.047  | 
 ≤0.060  | 
 ≤0.046  | 
 ≤0.057  | 
 ≤0.045  | 
 ≤0.055  | 
| 
 
  | 
 12 Years  | 
 13 Years  | 
 14 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 21.7-78.7  | 
 23.9-78.6  | 
 20.3-76.2  | 
 22.3-76.2  | 
 19.0-73.6  | 
 20.8-73.8  | 
| 
 Creatinine  | 
 28.7-55.7  | 
 33.8-61.0  | 
 29.1-57.7  | 
 35.9-64.8  | 
 29.5-59.5  | 
 38.1-68.5  | 
| 
 Guanidinoacetate  | 
 0.9-2.2  | 
 1.0-2.7  | 
 1.0-2.3  | 
 1.1-2.8  | 
 1.0-2.3  | 
 1.1-2.9  | 
| 
 Creatine/  | 
 ≤1.58  | 
 ≤1.68  | 
 ≤1.45  | 
 ≤1.50  | 
 ≤1.33  | 
 ≤1.34  | 
| 
 Guanidinoacetate/  | 
 ≤0.092  | 
 ≤0.093  | 
 ≤0.097  | 
 ≤0.101  | 
 ≤0.101  | 
 ≤0.109  | 
| 
 Guanidinoacetate/  | 
 ≤0.044  | 
 ≤0.053  | 
 ≤0.043  | 
 ≤0.051  | 
 ≤0.042  | 
 ≤0.050  | 
| 
 
  | 
 15 Years  | 
 16 Years  | 
 17 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 18.1-71.1  | 
 19.5-71.2  | 
 17.4-68.7  | 
 18.4-68.6  | 
 16.9-66.5  | 
 17.4-65.9  | 
| 
 Creatinine  | 
 29.9-61.3  | 
 40.4-71.9  | 
 30.4-62.9  | 
 42.4-75.0  | 
 30.9-64.4  | 
 44.2-77.6  | 
| 
 Guanidinoacetate  | 
 1.0-2.3  | 
 1.2-2.9  | 
 1.1-2.3  | 
 1.3-3.0  | 
 1.1-2.3  | 
 1.3-3.1  | 
| 
 Creatine/  | 
 ≤1.22  | 
 ≤1.20  | 
 ≤1.12  | 
 ≤1.07  | 
 ≤1.04  | 
 ≤0.97  | 
| 
 Guanidinoacetate/  | 
 ≤0.104  | 
 ≤0.117  | 
 ≤0.107  | 
 ≤0.125  | 
 ≤0.109  | 
 ≤0.132  | 
| 
 Guanidinoacetate/  | 
 ≤0.041  | 
 ≤0.049  | 
 ≤0.040  | 
 ≤0.048  | 
 ≤0.040  | 
 ≤0.048  | 
| 
 
  | 
 18 Years  | 
 19 Years  | 
 20 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 16.7-64.4  | 
 16.6-63.3  | 
 16.6-62.7  | 
 15.8-60.7  | 
 16.5-61.1  | 
 15.2-58.3  | 
| 
 Creatinine  | 
 31.3-65.8  | 
 45.6-80.0  | 
 31.8-67.0  | 
 46.7-82.0  | 
 32.2-68.2  | 
 47.4-83.9  | 
| 
 Guanidinoacetate  | 
 1.1-2.4  | 
 1.4-3.1  | 
 1.1-2.4  | 
 1.4-3.2  | 
 1.1-2.4  | 
 1.5-3.2  | 
| 
 Creatine/  | 
 ≤0.98  | 
 ≤0.87  | 
 ≤0.93  | 
 ≤0.80  | 
 ≤0.89  | 
 ≤0.73  | 
| 
 Guanidinoacetate/  | 
 ≤0.111  | 
 ≤0.139  | 
 ≤0.112  | 
 ≤0.145  | 
 ≤0.113  | 
 ≤0.150  | 
| 
 Guanidinoacetate/  | 
 ≤0.039  | 
 ≤0.047  | 
 ≤0.038  | 
 ≤0.047  | 
 ≤0.038  | 
 ≤0.046  | 
| 
 
  | 
 21 Years  | 
 22 Years  | 
 23 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 16.6-59.8  | 
 14.7-56.0  | 
 16.6-58.8  | 
 14.2-54.0  | 
 16.7-57.9  | 
 13.7-52.2  | 
| 
 Creatinine  | 
 32.5-69.2  | 
 47.9-85.6  | 
 32.8-70.2  | 
 48.2-87.2  | 
 33.1-71.1  | 
 48.4-88.8  | 
| 
 Guanidinoacetate  | 
 1.1-2.4  | 
 1.5-3.2  | 
 1.1-2.5  | 
 1.5-3.3  | 
 1.1-2.5  | 
 1.6-3.3  | 
| 
 Creatine/  | 
 ≤0.87  | 
 ≤0.68  | 
 ≤0.85  | 
 ≤0.64  | 
 ≤0.84  | 
 ≤0.61  | 
| 
 Guanidinoacetate/  | 
 ≤0.114  | 
 ≤0.156  | 
 ≤0.115  | 
 ≤0.161  | 
 ≤0.116  | 
 ≤0.165  | 
| 
 Guanidinoacetate/  | 
 ≤0.037  | 
 ≤0.045  | 
 ≤0.037  | 
 ≤0.045  | 
 ≤0.037  | 
 ≤0.044  | 
| 
 
  | 
 24 Years  | 
 25 Years  | 
 26 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 16.7-57.2  | 
 13.3-50.6  | 
 16.7-56.5  | 
 12.9-49.3  | 
 16.7-56.0  | 
 12.5-48.1  | 
| 
 Creatinine  | 
 33.3-71.9  | 
 48.6-90.2  | 
 33.6-72.8  | 
 48.7-91.5  | 
 33.7-73.6  | 
 48.9-92.7  | 
| 
 Guanidinoacetate  | 
 1.1-2.5  | 
 1.6-3.3  | 
 1.1-2.5  | 
 1.6-3.3  | 
 1.1-2.6  | 
 1.6-3.4  | 
| 
 Creatine/  | 
 ≤0.84  | 
 ≤0.58  | 
 ≤0.84  | 
 ≤0.56  | 
 ≤0.84  | 
 ≤0.54  | 
| 
 Guanidinoacetate/  | 
 ≤0.116  | 
 ≤0.170  | 
 ≤0.117  | 
 ≤0.174  | 
 ≤0.118  | 
 ≤0.179  | 
| 
 Guanidinoacetate/  | 
 ≤0.036  | 
 ≤0.043  | 
 ≤0.036  | 
 ≤0.043  | 
 ≤0.036  | 
 ≤0.042  | 
| 
 
  | 
 27 Years  | 
 28 Years  | 
 29 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 16.7-55.5  | 
 12.1-47.1  | 
 16.6-55.1  | 
 11.8-46.3  | 
 16.5-54.7  | 
 11.5-45.4  | 
| 
 Creatinine  | 
 33.9-74.4  | 
 49.0-93.7  | 
 34.1-75.2  | 
 49.1-94.5  | 
 34.2-76.0  | 
 49.2-95.3  | 
| 
 Guanidinoacetate  | 
 1.1-2.6  | 
 1.6-3.4  | 
 1.1-2.6  | 
 1.6-3.4  | 
 1.1-2.6  | 
 1.6-3.4  | 
| 
 Creatine/  | 
 ≤0.84  | 
 ≤0.52  | 
 ≤0.84  | 
 ≤0.51  | 
 ≤0.84  | 
 ≤0.49  | 
| 
 Guanidinoacetate/  | 
 ≤0.118  | 
 ≤0.182  | 
 ≤0.119  | 
 ≤0.186  | 
 ≤0.119  | 
 ≤0.188  | 
| 
 Guanidinoacetate/  | 
 ≤0.036  | 
 ≤0.042  | 
 ≤0.036  | 
 ≤0.041  | 
 ≤0.036  | 
 ≤0.041  | 
| 
 
  | 
 30 Years  | 
 31 Years  | 
 32 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 16.4-54.2  | 
 11.3-44.7  | 
 16.4-53.8  | 
 11.1-43.9  | 
 16.3-53.4  | 
 11.0-43.2  | 
| 
 Creatinine  | 
 34.4-76.8  | 
 49.3-96.0  | 
 34.6-77.5  | 
 49.3-96.7  | 
 34.7-78.2  | 
 49.4-97.4  | 
| 
 Guanidinoacetate  | 
 1.2-2.7  | 
 1.6-3.5  | 
 1.2-2.7  | 
 1.6-3.5  | 
 1.2-2.7  | 
 1.6-3.5  | 
| 
 Creatine/  | 
 ≤0.84  | 
 ≤0.48  | 
 ≤0.83  | 
 ≤0.47  | 
 ≤0.83  | 
 ≤0.46  | 
| 
 Guanidinoacetate/  | 
 ≤0.120  | 
 ≤0.190  | 
 ≤0.120  | 
 ≤0.192  | 
 ≤0.119  | 
 ≤0.192  | 
| 
 Guanidinoacetate/  | 
 ≤0.036  | 
 ≤0.041  | 
 ≤0.036  | 
 ≤0.042  | 
 ≤0.037  | 
 ≤0.042  | 
| 
 
  | 
 33 Years  | 
 34 Years  | 
 35 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 16.3-53.0  | 
 10.9-42.5  | 
 16.4-52.7  | 
 10.8-41.7  | 
 16.4-52.3  | 
 10.7-41.0  | 
| 
 Creatinine  | 
 34.9-78.8  | 
 49.4-98.0  | 
 35.1-79.4  | 
 49.5-98.6  | 
 35.3-79.9  | 
 49.5-99.2  | 
| 
 Guanidinoacetate  | 
 1.2-2.8  | 
 1.6-3.5  | 
 1.2-2.8  | 
 1.6-3.5  | 
 1.2-2.8  | 
 1.6-3.4  | 
| 
 Creatine/  | 
 ≤0.82  | 
 ≤0.45  | 
 ≤0.82  | 
 ≤0.45  | 
 ≤0.82  | 
 ≤0.44  | 
| 
 Guanidinoacetate/  | 
 ≤0.119  | 
 ≤0.192  | 
 ≤0.118  | 
 ≤0.191  | 
 ≤0.118  | 
 ≤0.189  | 
| 
 Guanidinoacetate/  | 
 ≤0.037  | 
 ≤0.042  | 
 ≤0.037  | 
 ≤0.042  | 
 ≤0.037  | 
 ≤0.042  | 
| 
 
  | 
 36 Years  | 
 37 Years  | 
 38 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 16.5-52.0  | 
 10.7-40.2  | 
 16.7-51.6  | 
 10.6-39.5  | 
 16.9-51.3  | 
 10.6-38.9  | 
| 
 Creatinine  | 
 35.4-80.3  | 
 49.5-99.8  | 
 35.6-80.7  | 
 49.5-100.3  | 
 35.8-81.0  | 
 49.6-100.8  | 
| 
 Guanidinoacetate  | 
 1.2-2.8  | 
 1.6-3.4  | 
 1.2-2.8  | 
 1.6-3.4  | 
 1.2-2.9  | 
 1.6-3.4  | 
| 
 Creatine/  | 
 ≤0.82  | 
 ≤0.44  | 
 ≤0.82  | 
 ≤0.44  | 
 ≤0.83  | 
 ≤0.44  | 
| 
 Guanidinoacetate/  | 
 ≤0.117  | 
 ≤0.187  | 
 ≤0.115  | 
 ≤0.184  | 
 ≤0.114  | 
 ≤0.182  | 
| 
 Guanidinoacetate/  | 
 ≤0.037  | 
 ≤0.042  | 
 ≤0.037  | 
 ≤0.042  | 
 ≤0.036  | 
 ≤0.042  | 
| 
 
  | 
 39 Years  | 
 40 Years  | 
 41 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 17.1-51.1  | 
 10.6-38.2  | 
 17.3-50.9  | 
 10.7-37.7  | 
 17.5-50.8  | 
 10.7-37.2  | 
| 
 Creatinine  | 
 35.9-81.4  | 
 49.6-101.3  | 
 36.0-81.6  | 
 49.6-101.7  | 
 36.1-81.9  | 
 49.7-102.1  | 
| 
 Guanidinoacetate  | 
 1.2-2.9  | 
 1.6-3.4  | 
 1.2-2.9  | 
 1.6-3.4  | 
 1.2-2.9  | 
 1.6-3.4  | 
| 
 Creatine/  | 
 ≤0.83  | 
 ≤0.44  | 
 ≤0.83  | 
 ≤0.44  | 
 ≤0.84  | 
 ≤0.44  | 
| 
 Guanidinoacetate/  | 
 ≤0.113  | 
 ≤0.179  | 
 ≤0.111  | 
 ≤0.176  | 
 ≤0.110  | 
 ≤0.174  | 
| 
 Guanidinoacetate/  | 
 ≤0.036  | 
 ≤0.041  | 
 ≤0.036  | 
 ≤0.041  | 
 ≤0.036  | 
 ≤0.040  | 
| 
 
  | 
 42 Years  | 
 43 Years  | 
 44 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 17.7-50.8  | 
 10.8-36.7  | 
 17.8-50.8  | 
 10.9-36.3  | 
 17.8-50.9  | 
 11.0-36.0  | 
| 
 Creatinine  | 
 36.2-82.1  | 
 49.7-102.5  | 
 36.3-82.4  | 
 49.8-102.8  | 
 36.4-82.6  | 
 49.8-103.1  | 
| 
 Guanidinoacetate  | 
 1.2-3.0  | 
 1.6-3.3  | 
 1.2-3.0  | 
 1.6-3.3  | 
 1.2-3.0  | 
 1.6-3.3  | 
| 
 Creatine/  | 
 ≤0.84  | 
 ≤0.44  | 
 ≤0.84  | 
 ≤0.43  | 
 ≤0.84  | 
 ≤0.43  | 
| 
 Guanidinoacetate/  | 
 ≤0.109  | 
 ≤0.172  | 
 ≤0.108  | 
 ≤0.171  | 
 ≤0.107  | 
 ≤0.170  | 
| 
 Guanidinoacetate/  | 
 ≤0.036  | 
 ≤0.039  | 
 ≤0.036  | 
 ≤0.039  | 
 ≤0.036  | 
 ≤0.038  | 
| 
 
  | 
 45 Years  | 
 46 Years  | 
 47 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 17.7-51.0  | 
 11.1-35.6  | 
 17.6-51.2  | 
 11.2-35.3  | 
 17.4-51.4  | 
 11.3-35.1  | 
| 
 Creatinine  | 
 36.4-82.8  | 
 49.9-103.4  | 
 36.5-83.0  | 
 49.9-103.6  | 
 36.5-83.2  | 
 49.9-103.9  | 
| 
 Guanidinoacetate  | 
 1.2-3.0  | 
 1.7-3.3  | 
 1.2-3.1  | 
 1.7-3.3  | 
 1.2-3.1  | 
 1.7-3.3  | 
| 
 Creatine/  | 
 ≤0.84  | 
 ≤0.42  | 
 ≤0.83  | 
 ≤0.41  | 
 ≤0.83  | 
 ≤0.40  | 
| 
 Guanidinoacetate/  | 
 ≤0.106  | 
 ≤0.169  | 
 ≤0.106  | 
 ≤0.168  | 
 ≤0.106  | 
 ≤0.167  | 
| 
 Guanidinoacetate/  | 
 ≤0.037  | 
 ≤0.038  | 
 ≤0.037  | 
 ≤0.037  | 
 ≤0.037  | 
 ≤0.037  | 
| 
 
  | 
 48 Years  | 
 49 Years  | 
 50 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 17.2-51.7  | 
 11.5-34.8  | 
 17.1-51.9  | 
 11.6-34.6  | 
 17.0-52.1  | 
 11.7-34.4  | 
| 
 Creatinine  | 
 36.6-83.4  | 
 49.9-104.1  | 
 36.6-83.5  | 
 49.9-104.2  | 
 36.7-83.7  | 
 49.9-104.4  | 
| 
 Guanidinoacetate  | 
 1.2-3.1  | 
 1.7-3.3  | 
 1.2-3.1  | 
 1.7-3.3  | 
 1.2-3.1  | 
 1.7-3.3  | 
| 
 Creatine/  | 
 ≤0.82  | 
 ≤0.39  | 
 ≤0.82  | 
 ≤0.38  | 
 ≤0.82  | 
 ≤0.38  | 
| 
 Guanidinoacetate/  | 
 ≤0.106  | 
 ≤0.166  | 
 ≤0.106  | 
 ≤0.164  | 
 ≤0.105  | 
 ≤0.163  | 
| 
 Guanidinoacetate/  | 
 ≤0.038  | 
 ≤0.036  | 
 ≤0.038  | 
 ≤0.036  | 
 ≤0.039  | 
 ≤0.036  | 
| 
 
  | 
 51 Years  | 
 52 Years  | 
 53 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 17.0-52.2  | 
 11.9-34.3  | 
 17.1-52.3  | 
 12.0-34.3  | 
 17.3-52.4  | 
 12.2-34.3  | 
| 
 Creatinine  | 
 36.8-83.9  | 
 49.8-104.6  | 
 36.8-84.0  | 
 49.8-104.8  | 
 36.9-84.2  | 
 49.8-104.9  | 
| 
 Guanidinoacetate  | 
 1.2-3.1  | 
 1.7-3.3  | 
 1.2-3.1  | 
 1.7-3.2  | 
 1.2-3.1  | 
 1.6-3.2  | 
| 
 Creatine/  | 
 ≤0.82  | 
 ≤0.37  | 
 ≤0.82  | 
 ≤0.37  | 
 ≤0.82  | 
 ≤0.38  | 
| 
 Guanidinoacetate/  | 
 ≤0.105  | 
 ≤0.161  | 
 ≤0.104  | 
 ≤0.159  | 
 ≤0.103  | 
 ≤0.157  | 
| 
 Guanidinoacetate/  | 
 ≤0.039  | 
 ≤0.036  | 
 ≤0.039  | 
 ≤0.036  | 
 ≤0.039  | 
 ≤0.036  | 
| 
 
  | 
 54 Years  | 
 55 Years  | 
 56 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 17.6-52.5  | 
 12.4-34.3  | 
 18.1-52.6  | 
 12.5-34.4  | 
 18.6-52.7  | 
 12.6-34.4  | 
| 
 Creatinine  | 
 37.0-84.4  | 
 49.8-105.0  | 
 37.1-84.5  | 
 49.8-105.2  | 
 37.2-84.7  | 
 49.8-105.3  | 
| 
 Guanidinoacetate  | 
 1.2-3.1  | 
 1.6-3.2  | 
 1.2-3.1  | 
 1.6-3.2  | 
 1.2-3.1  | 
 1.6-3.2  | 
| 
 Creatine/  | 
 ≤0.82  | 
 ≤0.38  | 
 ≤0.83  | 
 ≤0.39  | 
 ≤0.84  | 
 ≤0.40  | 
| 
 Guanidinoacetate/  | 
 ≤0.102  | 
 ≤0.155  | 
 ≤0.100  | 
 ≤0.154  | 
 ≤0.099  | 
 ≤0.152  | 
| 
 Guanidinoacetate/  | 
 ≤0.039  | 
 ≤0.036  | 
 ≤0.039  | 
 ≤0.036  | 
 ≤0.039  | 
 ≤0.036  | 
| 
 
  | 
 57 Years  | 
 58 Years  | 
 59 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 19.2-52.9  | 
 12.7-34.4  | 
 19.9-53.1  | 
 12.8-34.3  | 
 20.5-53.3  | 
 12.8-34.2  | 
| 
 Creatinine  | 
 37.3-84.9  | 
 49.8-105.4  | 
 37.4-85.1  | 
 49.8-105.5  | 
 37.6-85.2  | 
 49.8-105.6  | 
| 
 Guanidinoacetate  | 
 1.2-3.0  | 
 1.6-3.2  | 
 1.3-3.0  | 
 1.6-3.2  | 
 1.3-3.0  | 
 1.6-3.2  | 
| 
 Creatine/  | 
 ≤0.84  | 
 ≤0.40  | 
 ≤0.85  | 
 ≤0.41  | 
 ≤0.86  | 
 ≤0.42  | 
| 
 Guanidinoacetate/  | 
 ≤0.098  | 
 ≤0.151  | 
 ≤0.096  | 
 ≤0.151  | 
 ≤0.095  | 
 ≤0.150  | 
| 
 Guanidinoacetate/  | 
 ≤0.039  | 
 ≤0.036  | 
 ≤0.038  | 
 ≤0.036  | 
 ≤0.038  | 
 ≤0.036  | 
| 
 
  | 
 60 Years  | 
 61 Years  | 
 62 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 21.0-53.6  | 
 12.8-34.1  | 
 21.5-53.9  | 
 12.7-34.0  | 
 21.9-54.2  | 
 12.6-33.9  | 
| 
 Creatinine  | 
 37.8-85.4  | 
 49.9-105.7  | 
 38.0-85.5  | 
 49.9-105.9  | 
 38.3-85.7  | 
 49.9-106.0  | 
| 
 Guanidinoacetate  | 
 1.3-2.9  | 
 1.6-3.2  | 
 1.3-2.9  | 
 1.6-3.1  | 
 1.3-2.9  | 
 1.6-3.1  | 
| 
 Creatine/  | 
 ≤0.87  | 
 ≤0.43  | 
 ≤0.87  | 
 ≤0.44  | 
 ≤0.88  | 
 ≤0.44  | 
| 
 Guanidinoacetate/  | 
 ≤0.094  | 
 ≤0.150  | 
 ≤0.093  | 
 ≤0.150  | 
 ≤0.093  | 
 ≤0.150  | 
| 
 Guanidinoacetate/  | 
 ≤0.037  | 
 ≤0.036  | 
 ≤0.036  | 
 ≤0.035  | 
 ≤0.036  | 
 ≤0.035  | 
| 
 
  | 
 63 Years  | 
 64 Years  | 
 65 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 22.2-54.6  | 
 12.4-33.7  | 
 22.3-55.0  | 
 12.3-33.6  | 
 22.5-55.5  | 
 12.2-33.4  | 
| 
 Creatinine  | 
 38.7-85.8  | 
 50.0-106.1  | 
 39.1-85.9  | 
 50.0-106.3  | 
 39.6-86.1  | 
 50.1-106.4  | 
| 
 Guanidinoacetate  | 
 1.3-2.8  | 
 1.6-3.1  | 
 1.3-2.8  | 
 1.6-3.1  | 
 1.3-2.8  | 
 1.6-3.1  | 
| 
 Creatine/  | 
 ≤0.88  | 
 ≤0.45  | 
 ≤0.89  | 
 ≤0.46  | 
 ≤0.89  | 
 ≤0.46  | 
| 
 Guanidinoacetate/  | 
 ≤0.092  | 
 ≤0.150  | 
 ≤0.092  | 
 ≤0.149  | 
 ≤0.091  | 
 ≤0.149  | 
| 
 Guanidinoacetate/  | 
 ≤0.035  | 
 ≤0.035  | 
 ≤0.034  | 
 ≤0.034  | 
 ≤0.034  | 
 ≤0.034  | 
| 
 
  | 
 66 Years  | 
 67 Years  | 
 68 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 22.6-55.9  | 
 12.3-33.1  | 
 22.7-56.3  | 
 12.3-32.8  | 
 22.9-56.7  | 
 12.5-32.4  | 
| 
 Creatinine  | 
 40.2-86.2  | 
 50.2-106.6  | 
 40.7-86.3  | 
 50.3-106.7  | 
 41.3-86.5  | 
 50.4-106.9  | 
| 
 Guanidinoacetate  | 
 1.3-2.7  | 
 1.6-3.1  | 
 1.3-2.7  | 
 1.6-3.0  | 
 1.4-2.7  | 
 1.6-3.0  | 
| 
 Creatine/  | 
 ≤0.90  | 
 ≤0.47  | 
 ≤0.90  | 
 ≤0.48  | 
 ≤0.90  | 
 ≤0.48  | 
| 
 Guanidinoacetate/  | 
 ≤0.091  | 
 ≤0.149  | 
 ≤0.090  | 
 ≤0.148  | 
 ≤0.090  | 
 ≤0.148  | 
| 
 Guanidinoacetate/  | 
 ≤0.034  | 
 ≤0.034  | 
 ≤0.033  | 
 ≤0.034  | 
 ≤0.033  | 
 ≤0.034  | 
| 
 
  | 
 69 Years  | 
 70 Years  | 
 ≥ 71 Years  | 
|||
| 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
 Female  | 
 Male  | 
|
| 
 Creatine  | 
 23.2-57.0  | 
 12.8-32.0  | 
 23.6-57.2  | 
 13.1-31.4  | 
 24.1-57.3  | 
 13.6-30.8  | 
| 
 Creatinine  | 
 41.9-86.6  | 
 50.5-107.1  | 
 42.4-86.8  | 
 50.7-107.4  | 
 42.8-86.9  | 
 50.8-107.6  | 
| 
 Guanidinoacetate  | 
 1.4-2.6  | 
 1.6-3.0  | 
 1.4-2.6  | 
 1.6-3.0  | 
 1.4-2.5  | 
 1.5-3.0  | 
| 
 Creatine/  | 
 ≤0.90  | 
 ≤0.48  | 
 ≤0.90  | 
 ≤0.48  | 
 ≤0.90  | 
 ≤0.48  | 
| 
 Guanidinoacetate/  | 
 ≤0.090  | 
 ≤0.148  | 
 ≤0.090  | 
 ≤0.148  | 
 ≤0.090  | 
 ≤0.148  | 
| 
 Guanidinoacetate/  | 
 ≤0.033  | 
 ≤0.034  | 
 ≤0.033  | 
 ≤0.034  | 
 ≤0.033  | 
 ≤0.034  | 
Day(s) Performed
Tuesday
Report Available
3 to 9 daysPerforming Laboratory
 Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82540
82565
82542
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value | 
|---|---|---|
| CRDPS | Creatine Disorders Panel, S | In Process | 
| Result ID | Test Result Name | Result LOINC Value | 
|---|---|---|
| 608077 | Interpretation | 59462-2 | 
| 608078 | Creatine | 15045-8 | 
| 608079 | Creatinine | 14682-9 | 
| 608080 | Guanidinoacetate | 33244-5 | 
| 608081 | Creatine/Creatinine | In Process | 
| 610857 | Guanidinoacetate/Creatine | In Process | 
| 610858 | Guanidinoacetate/Creatinine | In Process | 
| 608082 | Reviewed By | 18771-6 |